Trials
Search / Trial NCT06442371

Additional Effects of Quranic Listening Meditation in Combination With High Intensity Interval Training in Obese Adults

Launched by RIPHAH INTERNATIONAL UNIVERSITY · May 29, 2024

Apply for Trial

Trial Information

Current as of March 13, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Obese adults (BMI ≥ 30)
  • • Age range: 18-45 years
  • • No previous experience with Quranic listening meditation since last 4 weeks.
  • • No contraindications for engaging in high-intensity physical activity
  • • Able to attend regular sessions at clinic and follow the study protocol.
  • • Willingness to undergo pre and post-assessments for cardiovascular fitness and mental health measures.
  • Exclusion Criteria:
  • • Individuals with a history of the medical condition being studied
  • • Those who are currently taking medication that may affect the study
  • • Participants with a history of mental health disorders
  • • Individuals who are pregnant or breastfeeding
  • • Those who have previously participated in a similar study
  • • Participants with a history of substance abuse or addiction

Trial Officials

Muhammad Iqbal Tariq, PhD*

Principal Investigator

Riphah International University

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Abbottābād, Khyber Pkahtoonkhwa, Pakistan

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0